These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9055837)

  • 1. An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women.
    Alonso M; Val E; Rapaport MH
    J Clin Psychiatry; 1997 Jan; 58(1):31. PubMed ID: 9055837
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study.
    Salzman C; Jimerson D; Vasile R; Watsky E; Gerber J
    Biol Psychiatry; 1993 Oct; 34(8):569-71. PubMed ID: 8274586
    [No Abstract]   [Full Text] [Related]  

  • 3. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
    Geretsegger C; Böhmer F; Ludwig M
    Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine-induced akathisia does not reappear after switch to paroxetine.
    Bauer M; Hellweg R; Baumgartner A
    J Clin Psychiatry; 1996 Dec; 57(12):593-4. PubMed ID: 9010125
    [No Abstract]   [Full Text] [Related]  

  • 5. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients.
    De Wilde J; Spiers R; Mertens C; Bartholomé F; Schotte G; Leyman S
    Acta Psychiatr Scand; 1993 Feb; 87(2):141-5. PubMed ID: 8447241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
    Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period.
    Kreider MS; Bushnell WD; Oakes R; Wheadon DE
    J Clin Psychiatry; 1995 Apr; 56(4):142-5. PubMed ID: 7713852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female sexual dysfunction and antidepressant use.
    Terao T
    Am J Psychiatry; 2001 Feb; 158(2):326-7. PubMed ID: 11156829
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.
    Amodeo LR; Greenfield VY; Humphrey DE; Varela V; Pipkin JA; Eaton SE; Johnson JD; Plant CP; Harmony ZR; Wang L; Crawford CA
    Psychopharmacology (Berl); 2015 Oct; 232(19):3515-28. PubMed ID: 26141193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressant guidelines poorly adhered to in young people].
    de Vries YA; de Jonge P; Kalverdijk L; Bos HJ; Schuiling-Veninga CC; Hak E
    Ned Tijdschr Geneeskd; 2016; 160():D627. PubMed ID: 27552937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine treatment of depressed patients with HIV infection.
    Judd FK; Mijch AM; Cockram A
    Aust N Z J Psychiatry; 1995 Sep; 29(3):433-6. PubMed ID: 8573046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
    Sclar DA; Robison LM; Skaer TL; Galin RS; Legg RF; Nemec NL; Hughes TE; Buesching DP; Morgan M
    J Int Med Res; 1995; 23(6):395-412. PubMed ID: 8746607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the long-term treatment of depression.
    Hirschfeld RM
    J Clin Psychiatry; 1994 Dec; 55 Suppl():61-9; discussion 70-1. PubMed ID: 7814359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine in the treatment of melancholia and severe depression.
    Tignol J; Stoker MJ; Dunbar GC
    Int Clin Psychopharmacol; 1992 Nov; 7(2):91-4. PubMed ID: 1487627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patients.
    Mesters P; Ansseau M; Brasseur R; Bussios G; Cosyns P; Czarka M; De Buck R; De Frenne A; Dierick M; Linkowski P
    Acta Psychiatr Belg; 1992; 92(4):232-45. PubMed ID: 1345403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.